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Summary
 
To investigate regulation of human immunoglobulin heavy chain expression, we have cloned
DNA downstream from the two human C
 
a
 
 genes, corresponding to the position in the mouse
IgH cluster of a locus control region (LCR) that includes an enhancer which regulates isotype
switching. Within 25 kb downstream of both the human immunoglobulin C
 
a
 
1 and C
 
a
 
2 genes
we identified several segments of DNA which display B lymphoid–specific DNase I hypersen-
sitivity as well as enhancer activity in transient transfections. The corresponding sequences
downstream from each of the two human C
 
a
 
 genes are nearly identical to each other. These
enhancers are also homologous to three regions which lie in similar positions downstream from
the murine C
 
a
 
 gene and form the murine LCR. The strongest enhancers in both mouse and
human have been designated HS12. Within a 135-bp core homology region, the human HS12
enhancers are 
 
z
 
90% identical to the murine homolog and include several motifs previously
demonstrated to be important for function of the murine enhancer; additional segments of high
sequence conservation suggest the possibility of previously unrecognized functional motifs. On
the other hand, certain functional elements in the murine enhancer, including a B cell–specific
activator protein site, do not appear to be conserved in human HS12. The human homologs of
the murine enhancers designated HS3 and HS4 show lower overall sequence conservation, but
for at least two of the functional motifs in the murine HS4 (a 
 
k
 
B site and an octamer motif) the
human HS4 homologs are exactly conserved. An additional hypersensitivity site between hu-
man HS3 and HS12 in each human locus displays no enhancer activity on its own, but includes
a region of high sequence conservation with mouse, suggesting the possibility of another novel
functional element.
 
T
 
he regulation of human immunoglobulin heavy chain
gene expression is incompletely understood, despite
clinically significant conditions in which specific isotypes
are inappropriately up- or downregulated, e.g., allergies
due to inappropriate IgE response, and various forms of
immunodeficiency associated with low IgA expression.
Clearly, cytokines and interactions between B and T cells
play a role in regulating isotype switching, and 
 
cis
 
 elements
in the IgH gene locus which mediate these effects have
been documented in the murine and human promoters of
the sterile transcripts associated with each heavy chain con-
stant region gene (1, 2). However, in the mouse an addi-
tional control region which contributes to regulation of
isotype switching has been reported to lie downstream
from C
 
a
 
, and the corresponding region of the human
heavy chain locus has not yet been investigated.
The existence of a regulatory region downstream from
murine C
 
a
 
 was originally inferred when it was found that
plasmacytomas which had undergone spontaneous dele-
tions of the only heavy chain enhancer then known, which
lies in the intron between JH and C
 
m
 
, nevertheless re-
mained capable of high level immunoglobulin secretion
(3–6). Conversely, a myeloma subclone which retained the
intronic enhancer but lost a segment of DNA downstream
from the murine C
 
a
 
 gene was found to have markedly re-
duced its heavy chain gene expression (7). A systematic
search in the homologous region of the rat heavy chain lo-
cus revealed an enhancer (8), and a homologous mouse en-
hancer designated 3
 
9a
 
E was found soon after (9, 10) posi-
tioned 
 
z
 
16 kb downstream from C
 
a
 
. The mouse and rat
3
 
9a
 
E segments lie in opposite orientations and are flanked
by inverted repeats (9). In addition to the 3
 
9a
 
E, Matthias
and Baltimore also reported a weak enhancer in mouse
lying only 4 kb downstream from C
 
a
 
 (Fig. 1 and refer-
ence 11).
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this work.
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Human 3
 
9
 
 IgH Enhancers
 
More recently, Madisen and Groudine (12) analyzed B
cell–specific DNase I hypersensitivity downstream from
C
 
a
 
 and identified four hypersensitive sites. HS1 and HS2
fall in the previously described 3
 
9a
 
E, whereas HS3 and
HS4 lie further downstream and identify two new regions
with somewhat weaker enhancer activity in transient trans-
fection assays. The HS3 sequence is almost identical to that
of the enhancer described by Matthias and Baltimore but
has an inverted orientation. This reflects the fact that the
sequence surrounding the HS12-3
 
9a
 
E is present in the
mouse in a long inverted repeat which includes HS3 se-
quences at both ends (Fig. 1 and reference 13). When con-
structs containing HS3, HS12, and HS4 linked to a re-
porter gene were transfected into a B cell line, subsequently
isolated stable transfectants were found to express the re-
porter gene in a position-independent manner. This sug-
gested that the three enhancer sequences (HS12, HS3, and
HS4) acted together as a locus control region (LCR)
 
1
 
.
LCRs, first defined in the globin locus (14), activate large
domains of chromatin in vivo (100 kb in the human 
 
b
 
globin locus), and, as components of DNA constructs in
transgenic mice, support gene expression proportional to
the number of integrated copies. In contrast, integrated
gene constructs lacking LCR sequences are variably ex-
pressed, depending on the positions of integration. LCRs
typically contain several DNase I hypersensitive sites, which
often represent DNA with enhancer activity. In addition to
the LCRs found in the 
 
b
 
 globin and mouse IgH loci,
LCRs have also been described as associated with mac-
rophage-specific lysozyme, CD2, and 
 
a
 
/
 
b
 
 TCR loci (15).
Analyses of the regulatory regions downstream from mu-
rine C
 
a
 
 have identified several motifs which bind specific
transcription factors to mediate different aspects of regula-
tion of enhancer function. The 3
 
9a
 
E has been found to ac-
tivate transcription strongly in plasmacytomas, but only
weakly in earlier B lymphoid cells. Part of this develop-
mental change is attributable to a motif known as E5, which
matches the “E-box” consensus binding site (CANNTG)
characteristic for members of the basic helix-loop-helix
family of transcription factors. The contribution of the E5
site to enhancer activity is inhibited in early stages of devel-
opment by the dominant negative nuclear regulator Id3,
which is expressed in early B lineage cells but downregu-
lated in plasma cells (16). At least four other motifs in the
3
 
9a
 
E have been reported to contribute to enhancer activity
specifically in plasmacytomas, motifs whose contribution in
B cells is inhibited by BSAP (the B cell–specific activator
protein), which disappears as B cells mature to plasma cells.
These sites include 
 
a
 
P (17), the octamer motif (ATG-
CAAAT; reference 18), a 
 
k
 
B-like site (16), and a G-rich
sequence (19). In B cells, BSAP prevents the binding of the
transcriptional activator NF-
 
a
 
P to the 
 
a
 
P site, and causes
the octamer, G-rich, and 
 
k
 
B-like motifs to exert an active
repressive influence on transcription (17, 19–21).
Apart from the motifs mediating upregulation of the
3
 
9a
 
E during maturation to plasma cells, a response element
in the enhancer for activation induced by B cell receptor
cross-linking has been traced to partially overlapping sites
for the ETS family member Elf-1 and for members of the
AP-1 transcription factor family (22). Two other motifs in
the enhancer have been proposed to contribute to its regu-
lation, but are less well documented: the 
 
m
 
E1 and the 
 
m
 
B
motifs, which were first noted in the rat 3
 
9a
 
E and which
are partially conserved in mouse. The HS3 and HS4 en-
hancer regions of mouse have been studied in less detail,
but the HS4 enhancer apparently contains functional Oct-1
and BSAP binding sites (23).
A role for the 3
 
9a
 
E in isotype switching was revealed by
experiments in which this region was replaced by a neomy-
cin resistance gene through homologous recombination in
embryonic stem cells which were then used to reconstitute
the B cell population in RAG-2 knockout mice. The re-
 
1
 
Abbreviations used in this paper:
 
 BAC, bacterial artificial chromosome;
BSAP, B cell–specific activator protein; HSE, heat shock element; HSTF,
heat shock transcription factors; LCR, locus control region.
Figure 1. Comparison of IgsH
loci of mouse and human. Line
A shows a map of the murine
IgH locus, from which the re-
gion downstream from Ca is ex-
panded in line B. The murine
enhancers designated Ca39E (11)
and 39aE (9) are shown as verti-
cal ovals, along with the DNase I
hypersensitivity site designations
(12). We have distinguished the
two copies of HS3 sequence as
HS3A and HS3B; these are in-
cluded in a large palindrome (ar-
rows) that flanks HS12, according
to the sequence analysis of
Chauveau and Cogné (13). Line
C shows the human IgH locus,
illustrating the g-g-e-a duplica-
tion units (brackets) and the possi-
bility of two regions homolo-
gous to the murine LCR. 
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sulting B cells showed normal V(D)J recombination but
marked deficiencies in switching to IgG2a, IgG2b, IgG3,
and IgE in vitro, whereas expression of IgM and IgG1 was
normal (24). This observation suggests that the enhancer
exerts isotype-specific effects on switch recombination,
possibly through its regulation of germline transcription of
the different isotypes before switch recombination.
Because the enhancer regions lying downstream from
the mouse C
 
a
 
 gene have been found to be important for
heavy chain gene expression and isotype switching, there
has been considerable interest in determining how homol-
ogous regions might regulate immunoglobulin gene ex-
pression in humans. The human heavy chain locus includes
two 
 
g
 
-
 
g
 
–
 
e
 
–
 
a
 
 segments (25, 26), apparently the product of
a large duplication in the primate lineage (27). Isotypes
from the upstream duplication, comprising the 
 
g
 
3-
 
g
 
1-
 
ce
 
-
 
a
 
1 constant region genes, are generally expressed at a much
higher level than those of the downstream 
 
g
 
2-
 
g
 
4-
 
e
 
-
 
a
 
2 du-
plication. The existence of two C
 
a
 
 genes in humans sug-
gests the possibility that two 3
 
9
 
 enhancer complexes may
regulate the locus, one downstream from each C
 
a
 
 gene;
differences in these complexes could contribute to the dif-
ferential regulation of the two duplications. Moreover, in-
dividuals who have a 
 
ce
 
-
 
a
 
1–
 
cg
 
 deletion on one chromo-
some show reduced expression of the downstream 
 
g
 
2 and
 
g
 
4 genes on that chromosome, indicating that this deletion
may have removed a region which exerts distal control
over at least some of the human heavy chain genes (28). Fi-
nally, the possibility that there are two 3
 
9a
 
 enhancer com-
plexes makes the human IgH locus an attractive candidate
for study because there could be interactions between two
adjacent LCRs, a situation which has not been described in
any other system.
Several laboratories have attempted to characterize se-
quences lying downstream from the two human C
 
a
 
 genes,
but technical difficulties have impeded this work. Gene
walking downstream from the C
 
a
 
 genes has been difficult,
apparently because of a segment of 20-bp tandem repeats
which lies almost immediately downstream of the most 3
 
9
 
exon of both C
 
a
 
 genes. These tandem repeats, described
independently by three laboratories (29–31), include the
sequence GATC recognized by the isoschizomer restric-
tion enzymes Sau3A and MboI. Since commercial human
DNA libraries in 
 
l
 
 phage have been constructed using ge-
nomic DNA fragments generated by partial MboI/Sau3A
digestion, the repeated Sau3A sites downstream of the C
 
a
 
genes make it unlikely that library clones isolated by hy-
bridization to C
 
a
 
 probes will contain DNA downstream
from the repeats.
As an initial step toward defining the role of global con-
trol regions in the activation of the human IgH genes, our
laboratory has sought to determine: (
 
a
 
) are enhancer com-
plexes located downstream from the human C
 
a
 
 genes; and
(
 
b
 
) how do any such human enhancers correspond to the
regulatory sequences described downstream from the mu-
rine C
 
a
 
 gene? Towards this end we have successfully ap-
plied several strategies other than gene walking from C
 
a
 
 to
obtain DNA clones extending downstream from the human
 
C
 
a
 
 genes, enabling us, by functional analysis and sequenc-
ing, to characterize enhancer regions 3
 
9
 
 of each C
 
a
 
 gene
homologous to those of the mouse HS12, HS3, and HS4.
 
Materials and Methods
 
Cloning of 3
 
9a
 
 Regions from Human Genomic DNA.
 
To ob-
tain DNA between C
 
a
 
1 and the previously reported 
 
cg
 
 pseudo-
gene which lacks associated S
 
g
 
 sequences, we initially sought
clones containing the pseudogene, which should hybridize to a
C
 
g
 
 probe but not to an S
 
g
 
 probe. We screened a commercial li-
brary of partial MboI-digested human placental DNA in the
 
l
 
FixII phage vector (Stratagene, La Jolla, CA) with a C
 
g
 
 probe:
probe f (Fig. 2), a 7-kb HindIII fragment, was isolated from
a pBR322 plasmid clone originally derived from 
 
l
 
 phage
CH·Ig·H·g-11(32) (Health Science Research Resources Bank,
Osaka, Japan; e-mail: hsrrb@nihs.go.jp). C
 
g1 plaques were re-
plated and duplicate plaque-lift filters were hybridized with the
Cg probe and an Sg probe (1,100-bp KpnI to PstI fragment con-
taining human Sg2; reference 33). Southern blots of BamHI-
digested DNA from eight candidate clones (Cg1, Sg2) were
hybridized with a 32P-labeled oligonucleotide Pseudogam-1 (see
Table 1 for sequences of oligonucleotides) specific for the cg
hinge region at 488C in hybridization buffer (1 M NaCl, 0.1 M
sodium phosphate, pH 7.0, 10% dextran sulfate, 10 mM EDTA,
1% SDS), followed by washing at 488C in 13 SSC, 10 mM
EDTA, 0.1% SDS. This analysis identified three overlapping
cg1 clones (cg-25, cg-2, and cg-38) extending over an z30-
kb region containing the cg gene (Fig. 2).
To obtain clones for the expected homologous region down-
stream of the Ca2 region, two probes derived from the farthest
upstream cg clone (cg-25) were used to rescreen two duplicate
plaque lifts of the lFIXII library. Probe b (Fig. 2) was a 4.5-kb
fragment extending from the 59 end of cg-25 to the first internal
EcoRI site. Probe e was a 1.3-kb PCR fragment which lies z2.5
kb upstream from cg and which was obtained by amplification
from a cg-25 subclone containing a 10.5-kb EcoRI-XbaI frag-
ment which extends from the farthest downstream EcoRI site in
cg-25 to an artificial XbaI site at the 39 end of the phage insert.
Primers used for this amplification were a reverse sequencing
primer (Table 1) and elkb2, a primer based on sequence data from
a cg-25 subclone. This probe contains a sequence homologous
to a gene encoding the transcription factor elk-1, which is known
to lie on the X chromosome (34). Clones EG3-6 and EG3-5
were selected for the following properties: they hybridized to
probe e but not to a Cg probe (as expected for DNA downstream
of Ca2), and they had restriction maps distinct from that of the
a1 locus and that of the elk-1 gene on the X chromosome, as es-
tablished by genomic Southern blots of DNA from a mouse/human
somatic hybrid cell line (NIGMS repository No. GM06318B;
Coriell Institute for Medical Research, Camden, NJ) carrying the
human X chromosome as its only human DNA. Clone H3E-1
was isolated on the basis of hybridization with probe b but not
with a Cg probe. By restriction maps and Southern blots, clones
H3E-1, EG3-6, and EG3-5 were found to overlap with each
other, forming a contig of z30 kb.
From genomic Southern blots, the phage contigs downstream
of the two Ca genes were found to lie z20 kb away from clones
containing the respective Ca genes. To bridge these gaps, a bac-
terial artificial chromosome (BAC) library of human genomic
DNA (Genome Systems, Inc., St. Louis, MO) was screened using
both a Ca membrane exon probe (Fig. 2, probe a) made by am-
plification from the Ca1 plasmid GMA5 using primer 59TM-A1848 Human 39 IgH Enhancers
in combination with primer 39TM-B (35) and a probe extending
from the most 59 HindIII site in cg-25 to a position z1,300 bp
upstream (Fig. 2, probe b9). A single BAC clone was obtained,
spanning z120 kb, from z20 kb upstream of Cg2 to 35 kb
downstream from the Ca2 membrane exon. From this clone,
designated BAC 11771, two subclones were prepared: a 10.5-kb
HindIII fragment (A2H10.5) and an overlapping 14-kb EcoRI
fragment (A2E14). Fragments of these subclones were found to
have sequence homology to murine HS12, HS3, and HS4, and
enhancer activity in a transient transfection assay (see Results).
Because several library screens were unsuccessful in identifying
phage or BAC clones covering the gap between Ca1 and our
downstream phage contig, selected DNA segments in this region
were amplified by PCR. Southern blots of human genomic DNA
indicated that the HS12 regions near a1 and a2 lie in opposite
orientation. This inversion made it possible to selectively amplify
a1-derived sequence from genomic DNA using two primers
which both corresponded to the sense strand of the a2 locus.
Amplification with the upstream primer SA2.5-A2 and the
downstream primer SA2.1-A2 was performed using Taq poly-
merase XL (PE Applied Biosystems, Foster City, CA) for 32 cy-
cles (948C for 1 min, 618C for 2 min, and 728C for 10 min), and
yielded the 5.5-kb A1-HS3-12 PCR fragment (Fig. 2). From this
fragment a 982-bp a1 HS-3 product was amplified using primers
SA2.5A and SA2.6A; and 964 bp a1HS12T and 892 bp
a1HS12B fragments were amplified using primers SA2.1A and
SA2.2B. For comparisons between enhancer activities of corre-
sponding a1 and a2 fragments, the homologous 1070-bp A2HS12
PCR product was generated with the same primer pair but using
plasmid pEH1.3 as template. In experiments seeking the a1 ho-
molog of HS4, amplifications exploiting the inversion were un-
successful. As an alternative strategy, we prepared an a1-specific
genomic template for PCR: a 23-kb HindIII fragment from the
human myeloma HS Sultan (American Type Culture Collection,
Rockville, MD) which Southern blots indicated extended from
the a1 membrane exon to a HindIII site in our cg-25 clone, in-
cluding DNA homologous to HS4. The corresponding regions
from a2 fall in 12-kb and 14-kb HindIII fragments. A 23-kb pre-
parative electrophoresis fraction of HindIII-digested DNA from
HS Sultan was used as template for amplification with primers
SA8.A and SA11.B based on sequence from the a2 locus. The re-
sulting 4.2-kb fragment (A1-HS4-39PCR; Fig. 2) was cloned
into a lZAP Express phage vector (Stratagene), yielding the
clone a1HS4-4.5; the cloned insert showed a restriction map
consistent with the a1 locus and distinct from the a2 locus. From
the 4.2 A1-HS4-39PCR fragment a 468-bp segment containing
the a1 HS4 region was amplified using primers SA.8A and
SA.9B; this segment was used for sequence analysis and enhancer
studies. With the same primer pair, the corresponding a2 frag-
ment A2-HS4 was generated using plasmid pA2E14 as template
in order to enable meaningful a1 versus a2 comparisons of HS4
enhancer activity.
DNase I Hypersensitive Site Analysis. Nuclei were prepared
and digested with DNase I according to a previously described
protocol (36). K562 and HS Sultan cells (both obtained from
American Type Culture Collection) were grown to densities of
5–8 3 105 cells/ml. For each experiment, 3–6 3 108 cells were
harvested, lysed by addition of NP-40, centrifuged through a 1.7 M
sucrose cushion, and resuspended in 5 ml; 450-ml aliquots of sus-
pended nuclei were treated with serially diluted DNase I (Boeh-
ringer-Mannheim, Indianapolis, IN) to give final DNase I con-
centrations of 0–8 mg/ml. Nuclei were digested with DNase I for 3
min at 258C. For one experiment HS Sultan nuclei were digested
with the restriction endonuclease SspI (New England Biolabs,
Beverly, MA) for 15 min at 378C. DNase I (or SspI) digestion
was terminated by adding 50 ml 1% SDS, 100 mM EDTA. DNA
samples were deproteinized for 5–48 h at 378C using proteinase
K (Boehringer-Mannheim) at a final concentration of 100 mg/ml.
DNA was purified by phenol/chloroform extraction and ethanol
precipitation, resuspended in 50–100 ml deionized water, and
DNA concentrations were measured using a Fluorometer (TKO
100; Hoeffer, San Francisco, CA). 5-mg DNA samples were di-
gested for 5–24 h in 50 ml of appropriate restriction enzyme
buffer with BglII, EcoRI, or HindIII (New England Biolabs). To
Figure 2. Regulatory loci
downstream of human Ca1 and
Ca2. Lines A and C, based on
this study, show an expanded
map of the region downstream
of Ca1 and Ca2, respectively, as
well as available DNA clones,
which are shown above (a1) or
below (a2) the line: phage
clones are marked with diagram-
matic phage heads, while the
subclones of PCR-amplified seg-
ments A1-HS3-12 and A1-HS4-
39 are drawn with hatched lines;
and a BAC clone is drawn as a
double line, containing a dele-
tion (dashed box). Vertical ovals
mark DNase I sites demonstrat-
ing enhancer activity and named
according to the homologous
murine HS sites. A series of small
triangles identifies the 20-bp re-
peats located downstream from
human Ca genes. X marks the
position of a DNase I site which shows human/mouse sequence conservation. The position of a CpG island previously identified by Southern blotting is
also shown (oval). The arrow under HS12 in line A indicates the orientation of this sequence, which is the same as that of the homologous mouse HS
site, but opposite from the orientation of HS12 in the a2 locus (line C). The thick black lines under the maps of lines A and C (single lower case letters) rep-
resent hybridization probes used in this study.849 Mills et al.
assess the SspI sensitivity of the b globin locus in HS Sultan nu-
clei, a 1,511-bp human b globin probe was amplified from total
human genomic DNA using primers b5PR-A and b3PR-B. Re-
striction-digested samples, together with 32P-labeled size markers,
were electrophoresed, blotted, and hybridized with the probes
indicated in the figure legends. After washing the membranes, ra-
dioactive images were obtained with a PhosphorImager (Molecu-
lar Dynamics, Sunnyvale, CA).
Enhancer Assays. To analyze DNA fragments for enhancer
activity, we used the luciferase reporter plasmid pGL3 (Promega
Corp., Madison, WI), modified so that the SV40 promoter be-
tween BglII and HindIII sites was replaced by a 76-bp Vk pro-
moter (37) containing an octamer motif and TATA box. This
plasmid, named pGL3-Vk, served as an enhancerless, promoter-
only control. Fragments to be assayed for enhancer activity were
blunt-ended with Klenow fragments of DNA polymerase and li-
gated with MluI linkers, or amplified with primers incorporating
an MluI (or KpnI) site; the fragments were then cloned into the
MluI (or KpnI) site in the polylinker upstream of the promoter in
pGL3-Vk. Plasmid DNAs for transfection were twice purified on
a CsCl gradient.
Approximately 5 3 106 cells in mid-log phase were washed
with PBS and electroporated with either 5 mg of promoter-only
control construct or equimolar amounts of enhancer test con-
structs along with 5 mg of CMV-b–galactosidase plasmid (pCMVb;
Clontech, Palo Alto, CA) as an internal control. Each plasmid
was electroporated in triplicate in 400 ml PBS using an Electro
Cell Manipulator (model 600; BTX Inc., San Diego, CA) at 200 V,
900 mF capacitance, and 13 V resistance in a 0.2-cm electropora-
tion cuvette. Immediately after transfection cells were returned to
culture medium. 24 h after transfection, the cells were harvested,
washed with PBS, and lysed in 50 ml reporter lysis buffer (Promega
Corp.) at room temperature for 20 min. After centrifugation at
15,000 rpm for 5 min, 15 ml of supernatant extracts were assayed
for b-galactosidase using Galacto-Light Plus Chemiluminescent
Reporter Assay kit (Tropix Inc., Bedford, MA) according to the
manufacturer’s instructions. To assay for luciferase activity, 35 ml
of cell extracts was incubated with 100 ml of luciferase substrate
[470 mM luciferin in 20 mM tricine, 1.07 mM (MgCO3) 3
Mg(OH)2 3 H2O, 2.67 mM MgSO4, 0.1 mM EDTA, 33.33 mM
DTT, 270 mM coenzyme A, and 540 mM ATP]. For both b-galac-
tosidase and luciferase assays light output was detected in a lumi-
nometer (Dynatech Instruments, Chantilly, VA).
Sequence Analysis. A PCR-based methodology employing
P33-labeled ddNTPs was used for sequencing reactions (Ther-
moSequenase kit; Amersham Life Science, Arlington Heights,
IL). All samples were amplified for 50 cycles (958C for 30 s; 608C
for 30 s; 728C for 60 s). Sequencing reactions were electropho-
resed on 6% gels, dried, autoradiographed, and read manually. All
reported sequences were read on both A and B strands, except for
the sequences of the HS12 59-bp repeats, which, despite several
attempts employing various strategies, could be read only on one
strand.
Results
Cloning DNA Downstream of Ca1 and Ca2. Because at-
tempts to clone the human 39 Ca regions using strategies
based on gene walking from Ca or cross-species hybridiza-
tion had failed in other laboratories, we used an alternative
strategy based on the fact that a Cg-like pseudogene (cg)
has been described downstream of human Ca1 (32, 38).
We reasoned that we could clone DNA downstream of
Ca1 by walking upstream from cg. The similarity in the
restriction maps reported downstream of the two Ca genes
Table 1.  Sequences of Oligonucleotides Used in This Study
Oligonucleotide name Sequence
Pseudogam-1 AGATGCCCACCATGTCAAGT
Reverse sequencing primer AACAGCTATGACCATG
elkb2 TAAGCTGTCTGAGAGAAAGGTTGGGGGAGG
59TM-A1 CTGTTCACACGAGTCTGGGCCTGG
39TM-B TCCAAGAGGTTCCTCCACACTTCC
SA2.5-A2 ggccggtaccGGATCCCGGTTCCTGATCACTG
SA2.1-A2 ggccggtaccCTTCCTGCCAACCTGGGGGCTG
SA2.5A ggccacgcgtGGATCCCGGTTCCTGATCACTG
SA2.6A ggccacgcgtCCACAGTCACTGCCAGATGCTC
SA2.1A ggccacgcgtCTTCCTGCCAACCTGGGGGCTG
SA2.2B ggccacgcgtGGCTTTTGCCAGTCCTCCTAC
SA11.B CAGTGCCCCAACCCAGGACGCCAGCC
SA.8A ggccacgcgtCGCTCGCTGCCCCACTCAGGAGG
SA.9B ggccacgcgtCTCCTAGCAGGGTCTCCTCCCTGG
b5PR-A GAGGAGAAGTCTGCCGTTACTGCCC
b3PR-B GGCACAATCCAGATGCTCAAGGCCC
All primer sequences are presented 59 to 39. For certain primers derived from human genomic DNA sequence, additional nucleotides were added at
the 59 end to provide restriction sites; these nongenomic nucleotides are written in lowercase letters, with the restriction site underlined. All oligonu-
cleotides were prepared in the Facility for Biotechnology Research (Center for Biologics Evaluation and Research, Bethesda, MD).850 Human 39 IgH Enhancers
based on Southern blotting (26) furthermore suggested that
these regions would be highly similar to each other. There-
fore, probes derived by walking upstream from cg should
also hybridize to clones containing DNA from downstream
of Ca2.
By screening a phage library for clones that hybridized to
Cg but not Sg, and then screening those clones with a cg-
specific oligonucleotide (see Materials and Methods), we
obtained three overlapping clones spanning z30 kb (Fig.
2). To obtain clones covering the corresponding region
from the a2 locus, the library was then rescreened with
probes b and e (Fig. 2). Clones deriving from downstream
of Ca2 were selected on the basis of restriction site differ-
ences between the a1 and a2 which had been established
by analysis of genomic Southern blots and comparisons
with our cloned DNA from the a1 duplication. Three
clones deriving from the a2 locus and spanning z30 kb
were obtained (Fig. 2).
To estimate the distance between our two phage contigs
and the corresponding Ca genes, we performed genomic
Southern blot experiments using a panel of restriction en-
zymes with known sites in the Ca loci and in our contigs.
For example, co-migrating BglII bands of z35 kb were
found to hybridize to both probe a (from the Ca mem-
brane exon am) and probe b (Fig. 2); these experiments
suggested a gap of z20 kb between each contig and the
corresponding membrane exon of Ca (data not shown).
For the a2 locus, the gap was bridged by a BAC clone (see
Materials and Methods). The corresponding regions from
the a1 locus have resisted direct cloning and have been ob-
tained by PCR using primers designed from the sequence
of the a2 locus, as described in Materials and Methods.
DNase I Hypersensitive Site Analysis. To map potential
regulatory sequences downstream of the Ca genes, we
used fragments from the cloned DNA downstream of the
Ca2 gene to search for DNase I hypersensitivity sites; in
cells where such enhancers or promoters are active, they
generally are hypersensitive to endonucleases, apparently
because binding of transcription factors disrupts the nu-
clease protection afforded by nucleosomes. Intact nuclei
from the human myeloma HS Sultan were incubated
briefly with various concentrations of DNase I; DNA sam-
ples purified from these treated nuclei were then analyzed
using several Southern blot strategies in order to localize
the positions of DNase I cleavage. The analyses were com-
plicated by the fact that all of the probes we used hybrid-
ized to both the a1 and a2 loci, but various restriction map
differences between the two loci allowed us to position all
the hypersensitivity sites with respect to restriction sites
mapped from our clones.
Fig. 3 A demonstrates analyses of DNA from the promy-
elocyte K562 line, representative of a cell not expressing
immunoglobulin genes, and the myeloma HS Sultan line.
The DNase I–treated DNA was digested with BglII, which
cuts z1 kb upstream of the membrane exon of both Ca
genes; the blots were hybridized with a probe correspond-
ing to this exon. Since the next downstream BglII site is
.20 kb away, this strategy can display hypersensitivity sites
over this wide distance from the a membrane exon. The
blot demonstrates at least seven hypersensitivity sites, which
were subsequently assigned to the a1 or a2 locus by other
blotting experiments and were named according to se-
quence similarity to the homologous murine regions as de-
scribed below. The sites we have tentatively designated
a1X and a2X do not correspond to any reported murine
enhancer sequence. None of these sites were visible in the
DNA from K562, in which the enhancer region is ex-
pected to be inactive.
The BglII blot of HS Sultan DNA fails to resolve the
two HS4 sites because they are too far away from the BglII
sites. The two HS4 sites were resolved by an alternative
Southern blot strategy employing EcoRI digests of the
DNA from DNase I–digested nuclei (Fig 3 B). To deter-
mine which of the two resulting bands represented HS4
from the a1 versus a2 loci, we exploited the observation
from our sequence analysis that recognition sites for the re-
striction enzyme SspI lie in each HS4 site. Since many reg-
ulatory regions accessible to DNase I are also accessible to
restriction endonucleases, we digested HS Sultan nuclei
with SspI and localized the cleavage sites by isolating the
DNA, digesting with EcoRI, and hybridizing Southern
blots with probe b9 as shown in Fig. 3 B. From the map
positions of the a1 and a2 SspI sites we assigned the SspI
hypersensitivity bands as shown in Fig. 3. A control exper-
iment on the same DNA isolated from SspI-digested HS
Sultan nuclei demonstrated that SspI recognition sites in
the b globin locus were not cut, indicating that the SspI
sites associated with HS4 were indeed hypersensitive in HS
Sultan cells (data not shown; see Materials and Methods).
Fig. 3 C illustrates an experiment which allowed assign-
ment of several HS sites to the a2 locus rather than a1.
DNA samples from DNase I–treated HS Sultan nuclei
were digested with HindIII and hybridized with a probe
for the HS12 site derived from the a2 locus. Although this
probe hybridizes to both the a1 and a2 loci, in this DNA
the a1 band is z23 kb, so large that any fragments from
this locus that were generated by HindIII and DNase I and
which hybridized to the probe would be larger than the
12-kb band representing the a2 locus. Thus all HS bands
,12 kb derive from a2. This blot therefore defines the po-
sition of the HS12, X, and HS3 sites in the a2 locus. By
implication, the other HS sites in the BglII blot of Fig. 3 A
must derive from a1. (It should be noted that a common
allele in other DNA samples shows an additional polymor-
phic HindIII site which cuts within the 23 kb correspond-
ing to the HS Sultan band; this allele would have con-
founded the above strategy, but was absent in HS Sultan.)
Enhancer Function. To analyze enhancer activity in the
cloned DNA downstream of the Ca2 locus, fragments
containing one or more DNase I hypersensitive sites were
subcloned into a luciferase reporter gene driven by a Vk
promoter as described in Materials and Methods. Luciferase
activity in each sample was normalized to the b-galactosi-
dase activity of the promoter-only control plasmid, and ex-
pressed as fold-increase over luciferase activity of that con-
trol plasmid.851 Mills et al.
The luciferase assays (Fig. 4) revealed strong enhancer
activity in the 5-kb SmaI-HindIII fragment (SM5) which
was found to contain sequence homologous to murine
HS12 (see below). Within this fragment, enhancer activity
seemed to be confined to the 1.3-kb EcoRI-HindIII frag-
ment (EH1.3) containing the HS12 site. This segment was
further cut into an upstream 0.3-kb EcoRI-PstI fragment
(EP300), a 0.3-kb PstI-PstI fragment (P300), and a 0.6-kb
PstI-HindIII fragment (PH600). Of these, only the P300
fragment, which contained HS12, showed enhancer activ-
ity. However, it should be noted that the enhancer activity
of P300 was less than that measured for a larger PCR-gen-
erated fragment A2HS12. Thus it is possible that additional
elements that do not show intrinsic enhancer activity when
Figure 3. Mapping of DNase I hypersensitive sites in the regions 39 of
the human Ca genes. (A) DNase I hypersensitive sites lie downstream
from the human Ca genes in the HS Sultan plasmacytoma. DNA samples
prepared from DNase I–digested nuclei isolated from K562 promyeloid
and HS Sultan myeloma cells were digested with BglII, electrophoresed,
blotted, and hybridized with probe a (am, Fig.1). No DNase I hypersen-
sitive sites are seen in the K562 samples. In contrast, at least seven DNase
I hypersensitive sites are observed in samples from HS Sultan plasmacy-
toma cells. The size of each DNase I–generated band corresponds to its
distance from the BglII sites located z1 kb 59 of each a membrane exon
(am). This mapping strategy does not distinguish between sites in the a1
versus a2 loci; sites are labeled according to their subsequent assignment
(see B and C, and sequence analyses). Due to their large size, bands result-
ing from DNase I cutting at the a1 and a2 HS4 sites are not resolved in
this analysis. (B) HS4 sites are accessible to nuclease in both a1 and a2
loci. HS Sultan nuclei were digested with DNase I or SspI restriction en-
zyme (both the a1 and a2 HS4 sequences contain an SspI site). Purified
DNA was digested with EcoRI and hybridized with probe b9, yielding
two closely spaced DNase I HS bands, whose sizes correspond to the ex-
pected distance between the HS4 enhancers and the downstream EcoRI
sites. Furthermore, there are two similarly positioned bands in the samples
from SspI-digested nuclei, indicating that both the a1 and a2 HS4 sites
are accessible to SspI. (C) Assignment of DNase I hypersensitive sites to
the 39 Ca2 region. HS Sultan DNA samples were digested with HindIII
and hybridized with probe g (a2 HS12, Fig. 1). Because DNAse I–gener-
ated bands from the a1 region which hybridize to this probe are expected to be larger than the 12-kb a2 HindIII fragment, all bands ,12 kb must result
from DNase I cutting in the 39 a2 region, with the size of these bands corresponding to their distance from the 39 end of the 12-kb a2 HindIII fragment.
This analysis allows assignment of three DNase I sites to the a2 locus, thus making it possible to assign the other hypersensitive sites seen in the BglII
analysis of Fig. 2 A to the a1 locus.852 Human 39 IgH Enhancers
isolated in constructs can nevertheless augment the activity
of the core HS12 enhancer lying in the P300 fragment.
Furthermore, the EH1.3 fragment, but not the slightly
shorter A2HS12 fragment, showed significantly less en-
hancer activity in the A orientation, suggesting the possibil-
ity of inhibitory sequences located near one of the ends of
EH1.3.
Two fragments containing the a2 HS3 site showed no
significant enhancer activity in the luciferase construct, but
a plasmid in which the HS3-containing 0.7-kb BamHI-
SmaI fragment was dimerized showed consistent low activ-
ity (Fig. 4, SM0.7-X2). The homologous murine enhancer
was reported to show greater activity with a c-myc pro-
moter than with an immunoglobulin Vl promoter (12),
but we found no significant increase in enhancer activity
when the Vk promoter was replaced by a human c-myc
promoter (data not shown; construct described in Materials
and Methods).
Two restriction fragments, B5.5 and SpB0.9, containing
the a2 HS4 site demonstrated significant stimulation of lu-
ciferase activity, but only when cloned in the B (inverted)
orientation (Fig. 4 A). When these fragments were ori-
ented so that the DNA strand continuous with the tran-
scribed strand in the luciferase gene corresponded to the
transcribed strand of the immunoglobulin gene in genomic
DNA (the A orientation), luciferase activity was no greater
than that from the promoter-only plasmid. Unexpectedly,
a smaller fragment (the 468-bp PCR-generated fragment
designated A2-HS4, designed to span the sequence show-
ing the strongest homology to the murine HS4 site) was
found to give a strong activation of luciferase activity. The
stronger activation of luciferase conferred by the short A2-HS4
PCR fragment compared with that of the longer SpB0.9 frag-
ment (in the same A orientation) suggests that the latter may
contain an inhibitory sequence that is either position- or orien-
tation-dependent. This possibility is currently being explored.
Because of the lack of genomic clones spanning the HS3,
HS12, and HS4 regions of a1 locus, fragments correspond-
ing to each of these sites were obtained by PCR and ana-
lyzed; and, to facilitate a1 versus a2 locus comparisons, the
same primer pairs were used to generate corresponding
fragments from the a2 locus. As shown in Fig. 4, the activ-
ity of each HS site fragment from a1 was similar to that
from the a2 locus (compare SM0.7-X2 a2 versus HS3-X2
a1; A2HS12 a2 versus A1HS12T a1; and A2-HS4 a2
versus A1-HS4 a1). The PCR amplification of the HS12
site yielded two fragments, designated A1HS12T (top) and
A1HS12B (bottom), which differ in size by ,0.1 kb and
may represent alleles (see below). Both fragments showed
substantial enhancer activity (Fig. 4 B).
Since the mouse 39a enhancers show different activation
patterns during B cell differentiation, with HS4 being acti-
vated at the pre–B cell stage, while HS12 and HS3 are only
active in mature B cells, we examined the activity of the
human 39 a2 enhancers in a range of human and mouse B
cell lines (Table 2). The pattern of activation for the human
HS12 enhancer is similar to that of mouse HS12; i.e., hu-
man HS12 is inactive in the human pro–B cell line FLEB-
14 and the mouse pre–B cell line 18-81, but functions in
the human mature B cell line Raji, as well as three plasma-
cytomas (HS Sultan, human; S194, mouse; and MOPC
315, mouse). HS3 is also inactive in mouse 18-81 pre–B
cell line, but shows modest activity in most of the more
mature lines tested. HS3 shows surprisingly strong activity
in the mouse S194 myeloma, indicating that unknown fac-
tors varying between cell lines at similar stages of differenti-
ation can modulate the activity of this enhancer. Finally,
the HS4 enhancer shows strong activity in the human pro-B
cell line FLEB14, and is also variably active in all of the more
mature cell lines (except 18-81) in which this enhancer was
assayed in the B orientation.
Sequence Analysis. The nucleotide sequence of all DNase
I hypersensitivity sites was determined, revealing z99% se-
Figure 4. Enhancer activity of selected regions downstream of human
Ca1 and Ca2 genes. (A) Analysis of the locus downstream of a2, which
was studied in detail. The map shows the position of DNase I sites; below
this are diagrammed the restriction sites defining the boundaries of each
fragment tested for enhancer activity by insertion into pGL3-Vk, trans-
fection into the human myeloma HS Sultan, and assay of resulting lu-
ciferase activity, as described in the text. The enhancer activities are given
for constructs in the A orientation (the same orientation with respect to
transcribed strands of immunoglobulin and luciferase) or the opposite B
orientation, where examined. The luciferase activities were normalized to
b-galactosidase activity encoded by a cotransfected plasmid, and expressed
as fold-increase over the activity of an enhancerless control plasmid. For
fragments showing enhancer activity, assays were performed at least in
triplicate, and standard deviations are given. (B) Comparable analysis of
selected fragments amplified from the homologous locus downstream
from Ca1.853 Mills et al.
quence identity between the human a1 and a2 elements,
and similarity between the human and mouse enhancers
ranging from 74 to 90%.
HS12, the strongest enhancer, showed 90% sequence
identity to the homologous murine enhancer over a 135-
bp core homology (Fig. 5 A). In the a2 locus, four tandem
repeats with a 59-bp consensus sequence lie immediately
upstream of the HS12 core. However, this sequence has
been inverted in Fig. 5 A, to facilitate comparison with the
homologous a1 sequence in opposite orientation. In the
corresponding region of a1 (which, due to the inversion,
lies downstream of the core homology region) a 115-bp
deletion removes the second and third repeats; the a1HS12B
region shows an additional deletion of 70 bp. The core ho-
mology region includes several of the functional motifs
identified in the murine enhancer: the AP1-Ets site re-
ported to confer responsiveness to B cell receptor cross-link-
ing (22, 39); an exact octamer sequence (ATGCAAAT);
and a mE5 site (except in the a1HS12B sequence, in which
the mE5 is missing owing to the 70-bp deletion). The se-
quences of these three motifs from the human HS12 are
identical to their murine homologs except for a single base
change in the AP1 site which causes the human sequence
to exactly match the consensus AP1 site, where the murine
motif has one mismatch. The murine element designated
mE1 (39), which has never been thoroughly documented
even in the murine enhancer, is poorly conserved in the
human homologs. Although the murine binding site for
NF-kB lies outside the 135-bp region of strongest se-
quence similarity, a reasonable match to consensus for this
element is found in a position roughly homologous to the
murine kB site in the a1HS12T and a2HS12 sequences,
but is part of the 70 bp deleted in a1HS12B. One of the
mouse BSAP sites (BSAP2) is not conserved, but most resi-
dues in a second mouse BSAP binding site (BSAP1) are
maintained in the human a2 HS12 enhancer. The murine
aP site, which binds to an ETS-related transcription factor
which augments enhancer activity (17), is not conserved in
the human sequences.
The DNase I hypersensitive sites lying ,3 kb down-
stream from the membrane exons of Ca1 and Ca2,
roughly in the position of the weak enhancer reported by
Matthias and Baltimore (11) and here designated HS3A,
were found to contain sequences which are 74% identical
to the murine HS3 over a 200 bp core segment. The two
human HS3 segments are identical in the 326 bp shown
(Fig. 5 B), and lie in the same orientation as HS3A. We
have assumed that the correct orientation of the murine
HS3A sequence is that described by Chauveau and Cogné
(13). This orientation is opposite to that of the murine
HS3B, which lies downstream from HS12 in the mouse, as
described by Madisen and Groudine (12). Of the en-
hancer/HS sites downstream of murine Ca, HS3 is the
least well investigated for functional motifs, in part because
of its weak enhancer activity. Independent sequence analy-
sis of the murine HS3A and HS3B regions detected several
similarities to octamer motifs, AP1 sites, and consensus E
box motifs (CANNTG). The AP1 site identified in Fig. 4
is a precise match to the consensus AP1 binding motif
TGANTCA (40) in the two human and two mouse HS3
sequences, and the murine sequence has been shown to
bind to c-jun and c-fos in vitro (Neurath, M., personal
communication). Similarly, several of the E box consensus
motifs in the murine sequence have been shown to bind in
vitro to proteins of the HLH family (Neurath, M., personal
communication); some of these motifs are conserved in the
two human HS3 sequences. The significance of the con-
served motifs remains uncertain in the absence of a func-
tional analysis of HS3 sequences.
The DNase I hypersensitivity sites furthest downstream
Table 2.  Cell Specifity of Human a2 Enhancer Elements
HS12 (EH1.3) HS3 (SM0.7) HS4 (SpB0.9)
Cell line A B A B X2 A B
Human
FLEB 14 (pro B) 1.9 6 0.1 1.9 6 0.1 ND ND ND 2.8 6 0.2 18.4 6 2.4
Raji (Mature B) 3.1 6 2.2 3.2 6 1.8 0.7 6 0.2 1.0 6 0.3 2.8 6 0.5 1.2 6 0.1 2.7 6 0.5
HS Sultan
(Plasmacytoma) 5.3 6 1.4 22 6 10 1.54 0.59 2.3 6 0.5 1.1 6 0.2 5.4 6 0.5
Mouse
18-81 (Pre-B) 0.9 6 0.2 1.1 6 0.3 1.2 6 0.1 0.8 6 0.2 1.6 6 0.5 0.5 6 0.1 0.9 6 0.2
S 194
(Plasmacytoma) 5.3 6 0.2 14.4 6 1.0 8.5 6 0.8 2.6 6 0.4 16.3 6 0.3 7.2 6 1.4 28.4 6 2.3
MOPC 315
(Plasmacytoma) 5.9 6 1.1 16.9 6 1.9 1.4 6 0.2 0.7 6 0.2 2.9 6 1.9 1.3 6 0.6 5.8 6 0.9
The numbers given represent the fold-increase of luciferase activity seen with a promoter-only control plasmid, with standard deviation. Numbers in
bold were judged to represent significant enhancer activity.854 Human 39 IgH Enhancers
from human Ca1 and Ca2 in Fig. 3, which we have desig-
nated HS4, are 76% similar to the murine HS4 site over a
core 145-bp sequence which spans the three functional
motifs demonstrated in murine HS4 (23); see Fig. 5 C. The
NF-kB motif and the downstream octamer motif in Fig. 5
C are both precisely conserved; in the murine HS4 these
motifs both contribute to functional enhancer activity (23).
In contrast, the BSAP site which upregulates murine HS4
enhancer activity in B cells but downregulates it in pre–B
cells is completely absent from the human HS4 sequences.
Lying between HS3 and HS12 in both the a1 and a2
loci are DNase I hypersensitive sites which are not associ-
ated with any of the known enhancer elements, but that do
map to the position of a 61-bp segment of 70% mouse-
human homology. These conserved regions are provision-
ally designated X sites in part because of their unknown
function, and in part because both the human and mouse
segments contain XbaI restriction enzyme sites. In mouse
this sequence is duplicated as part of the large inverted re-
peat centered on HS12, so that one copy lies between
HS3A and HS12 while a second copy lies between HS12
and HS3B. A segment of (GA)n repeats is found near the X
site in the direction of HS12 at an interval of 80 bp for
both mouse X sites (13) and an interval of z70 bp for the
human (data not shown). Within the 61-bp conserved seg-
ment, the most highly conserved sequence is a consensus
heat shock element (HSE; 41, 42). An HSE could poten-
tially bind heat shock transcription factors (HSTFs), which
are known to activate several heat shock response genes
(HSP70, HSP90) in response to cellular stress such as heat-
ing (43–45). Fragments containing an X site do not appear
to dramatically affect enhancer activity in HS Sultan, but
may contribute to regulation through mechanisms not cap-
tured in our transient transfection assays.
Discussion
Structure of Human 39 a Regions: Evolutionary Implica-
tions. The enhancers clustered 39 of Ca in the mouse IgH
locus can activate the upstream genes, functioning as an
LCR. In human IgH locus, arrays of enhancers homolo-
gous to those 39 of mouse Ca are located at two positions
within the human IgH locus, 39 of each Ca gene. On the
basis of sequence homology and conservation of restriction
Figure 5. Sequence similarities between human and mouse 39 a ele-
ments. Human-mouse alignments are shown between 39a enhancers
(H12, HS3, and HS4), as well as for the X DNase I site. Nucleotide
matches between human a1 and a2 sequences and between one or both
human sequences and mouse are indicated by shading. Core homology
regions are indicated by a thick line above the sequences. Boxes denote
motifs shown to function in mouse as transcription factor binding sites.
For HS12, HS3, and HS4, 50–100 bp of sequence flanking the core ho-
mology regions are shown. Mouse sequence numbering is 59 to 39 with regard to the coding strand of the mouse heavy chain locus. Numbering for
mouse HS12, HS3A, HS3B, and X segments is according to reference 13 (EMBL/GenBank/DDBJ accession numbers X96607 and X96608), while
numbering for mouse HS4 is according to reference 12 (EMBL/DDBJ/GenBank accession number S74166). (A) HS12 sequences (a2 sequence in-
verted). Overlining highlights the striking 135-bp core segment which is 90% homologous between human and mouse. The sequence alignment has
been extended downstream from the core to include additional transcription factor motifs which are functional in mouse. Vertical lines indicate the
boundaries of the GC-rich 59-bp repeat units. (B) HS3. Comparison of the nearly identical human a1 and a2 HS3 sequences with mouse HS3A and
HS3B sequences, which are also nearly identical, shows that there is a 200-bp core segment which is 74% homologous between the mouse and human
sequences. (C) HS4. Excluding the 25-bp gap containing the mouse HS4 BSAP site, the 145 core HS4 region is 76% homologous between human and
mouse. (D) X site. Near the center of a 61-bp segment which has 70% human-mouse homology, there is a 20-bp sequence which matches at 19 posi-
tions between humans and mice. In both mice and humans this segment contains a consensus HSE (41, 42). The sequences of the human enhancers and
X sites are available from EMBL/GenBank/DDBJ under accession numbers AF013718 (a1HS3), AF013719 (a2HS3), AF013720 (a1X), AF013721
(a2X), AF013722 (a1HS12T), AF013723 (a1HS12B), AF013724 (a2HS12), AF013725 (a1HS4), and AF013726 (a2HS4).855 Mills et al.
sites between the two human enhancer arrays, it is apparent
that these enhancers lie near the 39 ends of the two duplica-
tion units which encompass the g3-g1-ce-a1 and g2-g4-
e-a2 gene clusters (25–27), indicating that the 39a en-
hancer arrays were present in an approximation of the hu-
man arrangement preceding the duplication event that gave
rise to the present human IgH locus structure. Moreover,
the arrangement downstream of both human Ca genes is
59-HS3-HS12-HS4-39, in contrast to the large palindromic
structure downstream from mouse Ca that contains a
59-HS3A-HS12-HS3B-HS4-39 arrangement (13). There-
fore, although an arrangement containing an HS3 enhancer
proximal to the Ca membrane exon and an HS4 enhancer
farther downstream would seem to have been present in
the common ancestor of rodents and primates, the mouse
HS3A-HS12-HS3B palindrome probably arose after the
primate–rodent divergence. Finally, there is a major struc-
tural difference between the 39a1 and 39a2 enhancer ar-
rays; namely, that a DNA segment containing HS12 is in-
verted between the two loci. Using probes containing the
135-bp human HS12 core, it should now be possible to ex-
amine DNA from a number of primates for inversion of
39a2 HS12 relative to 39a1 HS12; such data may indicate
when in evolution the inversion event occurred, and
which orientation was present initially in the locus. What
caused this inversion? Interestingly, the single mouse HS12
lies in opposite orientation from the rat HS12, and both are
flanked by inverted repeats (13) which are known to medi-
ate inversions in other genomic contexts, e.g., in the idur-
onate-2-sulfatase gene causing Hunter syndrome (46) and
in the factor VIII gene (47). Limited Southern blot experi-
ments have not provided evidence for inverted repeats
flanking the human HS12 sequences (data not shown).
Some hints about the mechanism of the inversion may be
found when the inversion breakpoints are identified and
sequenced, work currently in progress in our laboratory.
HS12 Structure and Function. The 135-bp HS12 core
homology sequence is likely to contain essential motifs im-
portant for the strong, late, B cell–specific enhancer activity
characteristic of HS12 in mice and humans. Although the
function of transcription factor binding sites within the hu-
man HS12 core has not yet been demonstrated experimen-
tally, this segment contains sequences nearly identical to the
murine AP1, ETS, Oct, and, in a1HS12T and a2HS12, mE5
motifs, all of which are functional in the mouse HS12 en-
hancer. However, the high degree of sequence conserva-
tion in the HS12 core homology extends beyond the tran-
scription factor–binding sites identified in the mouse enhancer,
indicating that there may be additional conserved motifs
that have not been characterized in either mice or humans.
Despite the fact that a number of other transcription fac-
tor motifs whose function has been demonstrated in the
mouse HS12 lie outside the HS12 135-bp core homology
and are absent in one or more of the human a1HS12T,
a1HS12B, and a2HS12 enhancers that we have studied,
these enhancers all show roughly equivalent activities. This
result suggests that elements missing from these enhancers
are not essential for enhancer function in HS Sultan. These
inconsistently conserved elements include human sequences
corresponding to mE5 and NF-kB sites (absent from
a1HS12B) and the BSAP2 site (absent from both a1 alleles).
On the other hand, a 1.3-kb a2 EcoRI–HindIII fragment
containing the a2 HS12 core plus considerable flanking se-
quence shows a dependence of enhancer activity on orien-
tation of the fragment (Table 2), suggesting that uncharac-
terized elements beyond the HS12 core may have some
inhibitory function.
Outside the human HS12 core are GC-rich 59-bp repeat
units which by themselves do not have enhancer activity in
the HS Sultan myeloma (EP300, Fig. 4 A), and are not
conserved between mice and humans (Fig. 5 A). However,
it is possible that these repeats contribute to enhancer activ-
ity because they are present in the A2HS12 PCR-gener-
ated fragment, which gives significantly higher enhancer
activity than we observe in the p300 fragment containing
the core homology. Deletions of the 59-bp repeats have
given rise to apparent allelic polymorphisms, as evidenced
by a1HS12T (deletion of the second and third repeats
found in a2HS12), a1HS12 (deletion extending from 28
bp 59 of the first repeat through the third repeat), and other
alleles (Harindranath, N., unpublished results).
HS3 and HS4. The other two enhancer components
of the mouse 39a LCR, HS3 and HS4, are weaker enhanc-
ers than HS12, but nonetheless are essential for locus con-
trol activity (12). Although these elements are less well
characterized than the HS12 enhancer, the existing data in-
dicate general human–mouse similarity of the HS3 and
HS4 elements, with some notable differences.
In the mouse system, the HS3A element assayed in CAT
reporter gene constructs driven by c-fos or thymidine ki-
nase promoters (11) showed weak enhancer activity, although
the nearly identical HS3B enhancer showed substantial ac-
tivity in certain constructs with other promoters tested by
another laboratory (12). These disparate results resemble
our data on the human a1 and a2 HS3 elements in that
single copies and dimers of human HS3 generally gave very
low enhancer activity, except in the mouse S194 myeloma
in which the same constructs gave substantial enhancer ac-
tivity comparable to that of HS12 (Table 1). Taken to-
gether, these data suggest that HS3, though typically the
weakest of the 39a enhancers, contains uncharacterized
motifs that in some cells and/or in combination with cer-
tain promoters, can mediate a strong enhancer function.
HS4 is the most downstream 39a enhancer in both mice
and humans, and shows activity intermediate between that
of HS3 and HS12. The HS4 enhancer data in the mouse
(12, 48), as well as our data on the human a1 and a2 HS4
elements, demonstrate that HS4 is active from the early
stages of the B cell lineage onward (Table 2), and thus is
qualitatively different from HS3 and HS12. In mouse HS4,
there is a binding site for the BSAP, which is expressed in
the early B cell lineage. However, in the human a1 and a2
HS4 enhancers, the BSAP site is deleted, indicating that
BSAP binding is not an essential feature for HS4 activation856 Human 39 IgH Enhancers
in human pre–B cells. The human HS4 is inactive in the
18-81 mouse pre–B cell line, which was reported to sup-
port the activity of mouse HS4 (12). The significance of
this difference is not clear; it could be related to the BSAP
site deletion in the human HS4, or perhaps to other differ-
ences between the mouse and human HS4 sequences.
X Site. The DNase I X sites may represent novel con-
trol elements that function together with the HS3, HS12,
and HS4 enhancers to activate the IgH locus. Although the
significance of the conserved HSE motif is unclear, binding
of HSTF protein to an HSE has been shown to be critical
for maintaining the DNase I hypersensitivity of the yeast
HSC82 gene promoter (49). Heat shock activation of the
Drosophila HSP70 gene promoter results from binding of
HSTF to HSE sites after accessibility of the HSEs has been
established by binding of the GAGA protein to adjacent
(GA)n repeats (50). This demonstrated interaction between
HSEs and (GA)n motifs suggests that the location of a
(GA)n repeat region 70–80 bp away from the X site HSE
may be of some significance. Furthermore, in the context
of IgH gene regulation, it is of interest to note that HSE
motifs have been shown to respond to IL-2 and IL-4 (51).
Potential Locus Control Region. In the mouse, it has been
demonstrated that when HS3, HS12, and HS4 are linked
together in a construct containing the c-myc gene and sta-
bly transfected into the Raji human B cell line, the c-myc
gene is transcribed independent of integration site (12).
This observation suggests that the HS1234 combination
confers LCR activity, although LCRs have more typically
been described based on position-independent transcrip-
tion of mouse transgenes rather than genes transfected into
a cell line. Because the regions 39 of the human Ca1 and
Ca2 genes contain similar HS3, HS12, and HS4 elements
that function as enhancers, it is reasonable to hypothesize
that these elements also function together in the human
system as LCRs. The different arrangement of 39a enhanc-
ers in mice and humans (HS3A-HS12-HS3B-HS4 versus
HS3-HS12-HS4) may cause some functional differences in
these control regions. Moreover the distance between 39a en-
hancers also differs between mice and humans, with the mouse
enhancer complex spanning a 30-kb region (13), whereas
both the human 39a1 and 39a2 enhancers span z15 kb.
 Our finding that arrays of enhancers homologous to
those in the mouse 39a LCR lie downstream of both hu-
man Ca genes raises the possibility that differences in the
activation of each human g–g–e–a duplication unit result
from differences between the putative 39a1 and 39a2
LCRs. Even though sequence comparison shows that there
is near identity between homologous enhancer elements in
the a1 versus a2 locus (Fig. 5), transcription and expression of
the upstream heavy chain duplication unit (g3-g1-ce-a1) is
greatly elevated relative to the downstream unit (g2-g4-e-
a2; reference 2). This difference could result from the fact
that the 39a2 HS12 element is inverted relative to the 39a1
HS12, and is also at a greater distance from HS3 than in the
a1 locus, possibly reducing synergistic interactions between
HS3 and HS12. Alternatively, it may be that only the 39a1
enhancers are activated early in B cell development, possi-
bly falling under the influence of the upstream Em en-
hancer, which itself can function as an LCR (52, 53). In
this model, the Em and 39a1 enhancers together would ac-
tivate a large domain encompassing the first duplication
unit, whereas the second duplication unit and the 39a2 en-
hancers would fall outside this combined domain. Thus ac-
tivation of the second duplication unit would depend solely
on the 39a2 enhancers, and expression of genes in this unit
might therefore be reduced. Clarification of the basis for
this difference will have to await experiments that involve
specific deletion of either the 39a1 or 39a2 enhancers, as
well as studies identifying matrix attachment sites and chro-
matin insulator elements that define domains within the
human IgH region (52–54).
In the work presented here, we have laid the foundation
for experimental studies on the activation of the human
IgH gene transcription, as well as the regulation of isotype
switching. In addition, knowledge of the action of these
enhancers on distant constant region genes should contrib-
ute to a general understanding of the mechanisms underly-
ing activation of large gene clusters.
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Note added in proof. While this manuscript was under review, related investigations by two other laboratories
came to our attention. Chen, C., and B.K. Birshtein (1997. J. Immunol. 159:1310–1318.) have described the
HS12 enhancers from the a1 and a2 loci; and recently others have characterized the HS3 and HS12 enhanc-
ers from the a1 locus (M. Cogné, personal communication).857 Mills et al.
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